Constance, Germany

Christian Schudt

USPTO Granted Patents = 7 


Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 64(Granted Patents)


Location History:

  • Konstanz, DE (1995)
  • Constance, DE (2001 - 2014)

Company Filing History:


Years Active: 1995-2014

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Christian Schudt: Innovator in Pulmonary Hypertension Treatment

Introduction

Christian Schudt is a notable inventor based in Constance, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary hypertension. With a total of 7 patents to his name, Schudt's work has had a meaningful impact on pharmaceutical innovations.

Latest Patents

Among his latest patents is the invention related to Roflumilast for the treatment of pulmonary hypertension. This invention pertains to the use of Roflumilast, Roflumilast N-Oxide, or a pharmaceutically acceptable salt of either for treating this condition. Additionally, it explores the use of Roflumilast in combination with a PDE5 inhibitor or a pharmaceutically acceptable salt thereof for the same treatment. Another significant patent focuses on the use of PDE5 inhibitors in medicine, showcasing Schudt's commitment to advancing therapeutic options.

Career Highlights

Throughout his career, Christian Schudt has worked with prominent companies in the pharmaceutical industry. Notable among these are Byk Gulden Lomberg Chemische Fabrik GmbH and Altana Pharma AG. His experience in these organizations has contributed to his expertise and innovative capabilities in drug development.

Collaborations

Christian Schudt has collaborated with esteemed colleagues, including Ulrich Kilian and Torsten Dunkern. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Christian Schudt stands out as a significant figure in the field of pulmonary hypertension treatment. His inventions and collaborations reflect his dedication to improving medical therapies. His contributions continue to influence the pharmaceutical landscape positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…